Biblio
Found 2 results
Filters: Author is Caulin, Carlos and Keyword is Antibodies, Monoclonal [Clear All Filters]
.
2023. Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer.. J Clin Oncol. 41(22):3851-3862.
.
2017. PD-1 Blockade Prevents the Development and Progression of Carcinogen-Induced Oral Premalignant Lesions.. Cancer Prev Res (Phila). 10(12):684-693.